Kestra Medical Technologies, Ltd. (KMTS): who owns it and who trades it
As of Nov 16, 2026, KMTS insiders reported 54 open-market sales worth $15.5M and 1 purchase worth $200K in the last 12 months, with 42% of the sale value made under pre-set 10b5-1 plans. The largest seller was Brian Daniel Webster (Director), with $5.5M. 2 of the 50 famous funds we follow held it at their last quarter end.
Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.
At a glance
Who is buying and selling Kestra Medical Technologies
From the latest filingsOverall: about as much buying as selling. Insiders mostly sold. Funds mostly bought. Famous investors was close to even.
Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.
Who owns KMTS
110 funds and institutions reported KMTS shares worth $1.5B at the end of Q2 2026. Some shares are counted by more than one filer, or lent out and counted twice, so the total can pass 100%. The largest holder is Bain Capital Investors LLC with 43.1%.
Funds and institutions (13F) about 100%Everyone else 0%
10 largest owners, by share of the company
Top 20 owners
| Owner | Shares | % of company | Value | Change since Q1 2026 |
|---|---|---|---|---|
| Bain Capital Investors LLC | 25.17M | 43.12% | $640M | No change |
| FMR LLC (Fidelity) | 5.52M | 9.46% | $141M | -3% |
| T. Rowe Price Associates | 4.97M | 8.51% | $126M | -17% |
| Andera Partners | 2.73M | 4.67% | $69.4M | +1% |
| Yu Fan | 2.28M | 3.91% | $58.1M | No change |
| Brown Advisory Inc | 1.91M | 3.27% | $48.6M | +11% |
| BlackRock, Inc. | 1.87M | 3.20% | $47.5M | +10% |
| Alliancebernstein L.P. | 1.48M | 2.53% | $29.5M | +12% |
| Eventide Asset Management, LLC | 1.45M | 2.48% | $36.8M | +0% |
| Vanguard Capital Management LLC | 1.18M | 2.01% | $29.9M | -3% |
| Franklin Resources Inc | 1.12M | 1.92% | $28.6M | -10% |
| Omega Fund Management, LLC | 1.02M | 1.75% | $26M | No change |
| Hood River Capital Management LLC | 753,529 | 1.29% | $19.2M | +15% |
| State Street Corp | 747,703 | 1.28% | $19M | +11% |
| California State Teachers Retirement System | 686,422 | 1.18% | $27M | +2366% |
| Geode Capital Management, LLC | 647,380 | 1.11% | $16.5M | +13% |
| Point72 Asset Management, L.P. | 526,626 | 0.90% | $13.4M | – |
| Federated Hermes, Inc. | 525,000 | 0.90% | $13.4M | No change |
| Next Century Growth Investors LLC | 458,505 | 0.79% | $11.7M | +0% |
| Driehaus Capital Management LLC | 448,608 | 0.77% | $11.4M | +0% |
From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.
Insider trades
In the last 12 months, KMTS insiders reported $200K of open-market purchases and $15.5M of sales. 42% of the sale value was under a 10b5-1 plan, a schedule set up in advance.
Purchases and sales by month
Latest trades
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Nov 3, 2026 | Timothy P. Moran | Chief Business Officer | Sale | 3,192 | $29.56 | $94.4K | Form 4 |
| Oct 29, 2026 | Vaseem Mahboob | CFO | Sale plan | 4,788 | $30.60 | $147K | Form 4 |
| Oct 28, 2026 | Vaseem Mahboob | CFO | Sale plan | 39,903 | $30.48 | $1.2M | Form 4 |
| Oct 27, 2026 | Traci S Umberger | Director | Sale plan | 30,000 | $30.03 | $901K | Form 4 |
| Oct 27, 2026 | Vaseem Mahboob | CFO | Sale plan | 34,809 | $30.04 | $1M | Form 4 |
| Oct 21, 2026 | Traci S Umberger | Director | Sale plan | 96,404 | $27.15 | $2.6M | Form 4 |
| Oct 21, 2026 | Traci S Umberger | Director | Sale plan | 3,596 | $28.09 | $101K | Form 4 |
| Oct 20, 2026 | Brian Daniel Webster | Director | Sale plan | 13,316 | $29.52 | $393K | Form 4 |
| Oct 20, 2026 | Brian Daniel Webster | Director | Sale plan | 1,684 | $29.89 | $50.3K | Form 4 |
| Sep 30, 2026 | Raymond W Cohen | Director | Sale | 3,330 | $29.28 | $97.5K | Form 4 |
| Sep 21, 2026 | Elizabeth Kwo | Director | Sale | 4,010 | $24.26 | $97.3K | Form 4 |
| Sep 8, 2026 | Jeffrey Lawrence Schwartz | Director | Sale | 3,890 | $25.18 | $98K | Form 4 |
| Sep 8, 2026 | Conor Hanley | Director | Sale | 5,694 | $25.25 | $144K | Form 4 |
| Sep 8, 2026 | Kevin C Reilly | Director | Sale | 2,932 | $25.13 | $73.7K | Form 4 |
| Sep 8, 2026 | Mary Kay Ladone | Director | Sale | 3,908 | $25.20 | $98.5K | Form 4 |
| Aug 17, 2026 | Brian Daniel Webster | Director | Sale | 15,000 | $27.48 | $412K | Form 4 |
| Aug 7, 2026 | Vaseem Mahboob | CFO | Sale | 500 | $26.33 | $13.2K | Form 4 |
| Aug 7, 2026 | Vaseem Mahboob | CFO | Sale | 25,787 | $25.87 | $667K | Form 4 |
| Aug 4, 2026 | Alfred J Ford Jr | Chief Commercial Officer | Sale | 6,275 | $24.09 | $151K | Form 4 |
| Aug 4, 2026 | Vaseem Mahboob | CFO | Sale | 3,915 | $25.17 | $98.5K | Form 4 |
| Aug 4, 2026 | Vaseem Mahboob | CFO | Sale | 3,080 | $24.06 | $74.1K | Form 4 |
| Aug 4, 2026 | Traci S Umberger | Director | Sale | 3,580 | $24.04 | $86.1K | Form 4 |
| Aug 4, 2026 | Brian Daniel Webster | Director | Sale | 48,625 | $24.47 | $1.2M | Form 4 |
| Aug 4, 2026 | Brian Daniel Webster | Director | Sale | 442 | $25.98 | $11.5K | Form 4 |
| Aug 4, 2026 | Brian Daniel Webster | Director | Sale | 2,833 | $25.16 | $71.3K | Form 4 |
| Aug 3, 2026 | Timothy P. Moran | Chief Business Officer | Sale | 2,380 | $23.76 | $56.5K | Form 4 |
| Aug 3, 2026 | Alfred J Ford Jr | Chief Commercial Officer | Sale | 13,015 | $23.90 | $311K | Form 4 |
| Aug 3, 2026 | Vaseem Mahboob | CFO | Sale | 5,391 | $23.80 | $128K | Form 4 |
| Aug 3, 2026 | Traci S Umberger | Director | Sale | 7,590 | $23.86 | $181K | Form 4 |
| Aug 3, 2026 | Brian Daniel Webster | Director | Sale | 13,017 | $23.92 | $311K | Form 4 |
| Jul 31, 2026 | Timothy P. Moran | Chief Business Officer | Sale | 8,759 | $22.61 | $198K | Form 4 |
| Jul 31, 2026 | Alfred J Ford Jr | Chief Commercial Officer | Sale | 8,681 | $22.61 | $196K | Form 4 |
| Jul 31, 2026 | Vaseem Mahboob | CFO | Sale | 8,817 | $22.61 | $199K | Form 4 |
| Jul 31, 2026 | Traci S Umberger | Director | Sale | 8,752 | $22.60 | $198K | Form 4 |
| Jul 31, 2026 | Brian Daniel Webster | Director | Sale | 8,948 | $22.60 | $202K | Form 4 |
| Jul 30, 2026 | Timothy P. Moran | Chief Business Officer | Sale | 4,117 | $22.77 | $93.7K | Form 4 |
| Jul 30, 2026 | Alfred J Ford Jr | Chief Commercial Officer | Sale | 5,936 | $22.76 | $135K | Form 4 |
| Jul 30, 2026 | Vaseem Mahboob | CFO | Sale | 3,980 | $22.75 | $90.5K | Form 4 |
| Jul 30, 2026 | Traci S Umberger | Director | Sale | 5,887 | $22.74 | $134K | Form 4 |
| Jul 30, 2026 | Brian Daniel Webster | Director | Sale | 7,857 | $22.72 | $179K | Form 4 |
| Jul 15, 2026 | Brian Daniel Webster | Director | Sale | 11,216 | $22.01 | $247K | Form 4 |
| Jul 15, 2026 | Brian Daniel Webster | Director | Sale | 3,000 | $24.00 | $72K | Form 4 |
| Jul 15, 2026 | Brian Daniel Webster | Director | Sale | 784 | $22.63 | $17.7K | Form 4 |
| Jun 15, 2026 | Brian Daniel Webster | Director | Sale | 15,000 | $20.81 | $312K | Form 4 |
| May 15, 2026 | Brian Daniel Webster | Director | Sale | 6,845 | $21.46 | $147K | Form 4 |
| May 15, 2026 | Brian Daniel Webster | Director | Sale | 8,155 | $20.53 | $167K | Form 4 |
| Apr 15, 2026 | Brian Daniel Webster | Director | Sale | 15,000 | $20.04 | $301K | Form 4 |
| Mar 26, 2026 | Raymond W Cohen | Director | Purchase | 10,000 | $19.98 | $200K | Form 4 |
| Mar 17, 2026 | Brian Daniel Webster | Director | Sale | 15,000 | $20.27 | $304K | Form 4 |
| Feb 17, 2026 | Brian Daniel Webster | Director | Sale | 3,272 | $26.29 | $86K | Form 4 |
| Feb 17, 2026 | Brian Daniel Webster | Director | Sale | 93 | $27.18 | $2.5K | Form 4 |
| Feb 17, 2026 | Brian Daniel Webster | Director | Sale | 11,635 | $25.39 | $295K | Form 4 |
| Jan 15, 2026 | Brian Daniel Webster | Director | Sale | 15,000 | $22.80 | $342K | Form 4 |
| Dec 29, 2025 | Traci S Umberger | Director | Sale | 10,500 | $26.69 | $280K | Form 4 |
| Dec 29, 2025 | Brian Daniel Webster | Director | Sale | 15,000 | $26.59 | $399K | Form 4 |
Insiders by value traded
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Brian Daniel Webster | See Remarks, Director | – | $5.5M | Oct 20, 2026 |
| Traci S Umberger | See Remarks, Director | – | $4.5M | Oct 27, 2026 |
| Vaseem Mahboob | Chief Financial Officer | – | $3.7M | Oct 29, 2026 |
| Alfred J Ford Jr | Chief Commercial Officer | – | $794K | Aug 4, 2026 |
| Timothy P. Moran | Chief Business Officer | – | $443K | Nov 3, 2026 |
| Raymond W Cohen | Director | $200K | $97.5K | Sep 30, 2026 |
| Conor Hanley | Director | – | $144K | Sep 8, 2026 |
| Mary Kay Ladone | Director | – | $98.5K | Sep 8, 2026 |
| Jeffrey Lawrence Schwartz | Director, 10% owner | – | $98K | Sep 8, 2026 |
| Elizabeth Kwo | Director | – | $97.3K | Sep 21, 2026 |
| Kevin C Reilly | Director | – | $73.7K | Sep 8, 2026 |
What this data shows, and what it doesn't
- Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
- Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
- "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
- Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
- Filings are self-reported and can be amended. Each trade links to its original filing. Methodology
KMTS short interest
Moderate short interest. 6.9% of KMTS shares are sold short: about 1 share in 15. Over the last 12 reports the number of shares short went up 25%.
As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.
As of Oct 30, 2026, 4.10M KMTS shares were sold short, 6.9% of the shares outstanding, up 19.7% from the report before. At the average daily volume of 503,879 shares, buying them all back would take about 8.2 trading days (days to cover).
Shares short, % of all shares
Days to cover
Every report
| Settlement date | Shares short | % of shares | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|---|
| Oct 30, 2026 | 4.10M | 6.89% | +20% | 503,879 | 8.2 |
| Oct 15, 2026 | 3.43M | 5.76% | +5% | 279,041 | 12.3 |
| Sep 30, 2026 | 3.28M | 5.50% | +5% | 449,973 | 7.3 |
| Sep 15, 2026 | 3.12M | 5.24% | +5% | 374,462 | 8.3 |
| Aug 31, 2026 | 2.97M | 5.07% | -1% | 240,361 | 12.4 |
| Aug 14, 2026 | 3.02M | 5.15% | -8% | 337,026 | 8.9 |
| Jul 31, 2026 | 3.29M | 5.62% | +6% | 323,412 | 10.2 |
| Jul 15, 2026 | 3.10M | 5.28% | -8% | 510,281 | 6.1 |
| Jun 30, 2026 | 3.36M | 5.76% | +15% | 457,577 | 7.3 |
| Jun 15, 2026 | 2.93M | 5.02% | +2% | 326,703 | 9.0 |
| May 29, 2026 | 2.87M | 4.92% | -12% | 249,940 | 11.5 |
| May 15, 2026 | 3.28M | 5.62% | -5% | 265,602 | 12.3 |
Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks
Kestra Medical Technologies company events
Kestra Medical Technologies filed 7 reports on Form 8-K in the last 12 months, all of them routine, such as results and vote reports. The latest was on Sep 14, 2026.
- Sep 14, 2026ResultsReleased financial results. Filing
- Sep 10, 2026VoteReported shareholder vote results. Filing
- Jul 14, 2026AgreementKestra Medical Technologies, Ltd., its wholly-owned subsidiary, Kestra Medical Technologies, Inc. and other credit parties thereto (collectively with the Borrower and the Company, the “Credit Parties”), entered into a loan agreement with BPCR Limited Partnership and BioPharma Credit Investments V… Filing
- Mar 17, 2026ResultsReleased financial results. Filing
- Dec 11, 2025ResultsReleased financial results. Filing
- Dec 4, 2025AgreementKestra Medical Technologies, Ltd., a Bermuda exempted company entered into an Underwriting Agreement with BofA Securities, Inc., Piper Sandler & Co., J.P. Morgan Securities LLC and Goldman Sachs & Co. LLC, as representatives of the several underwriters named therein, related to an underwritten… Filing
- Dec 1, 2025ResultsReleased financial results. Filing
From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week
Kestra Medical Technologies financials
Famous investors that hold KMTS
2 of the 50 well-known investors we track reported holding KMTS in their latest 13F filing. The largest position is Steve Cohen's, worth $13.8M.
| Fund | Quarter | Shares | Value | Of portfolio | Change |
|---|---|---|---|---|---|
| Steve Cohen · Point72 Asset Management | Q3 2026 | 489,279 | $13.8M | 0.0% | -7% |
| Israel Englander · Millennium Management | Q3 2026 | 211,418 | $6M | 0.0% | +29% |
From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.
Questions about Kestra Medical Technologies, Ltd. (KMTS) stock
Who owns the most KMTS stock?
The largest reported owner of Kestra Medical Technologies, Ltd. (KMTS) is Bain Capital Investors LLC, with 43.1% of the company. In total, 110 funds and institutions reported holding KMTS at the end of Q2 2026, together about 100% of the shares. See the largest owners.
Are KMTS insiders buying or selling?
In the last 12 months, KMTS insiders reported 1 open-market purchase worth $200K and 54 sales worth $15.5M. The latest trade was on Nov 3, 2026. See every trade.
What is the short interest in KMTS?
As of Oct 30, 2026, 4.10M KMTS shares were sold short, 6.9% of the shares outstanding, up 19.7% from the report before. At the average daily volume of 503,879 shares, buying them all back would take about 8.2 trading days (days to cover). See the history.
Which famous investors hold KMTS?
2 of the 50 well-known investors we track reported KMTS in their latest 13F filing, including Steve Cohen, Israel Englander. The largest position is worth $13.8M. See all holders.
Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.